Skip to main content

Glessner Coleen's Form 4 filing

Emergent BioSolutions Inc.EBS · filed Oct 16, 2025

Accession no.
0001919170-25-000004
Filed
Oct 16, 2025
Trade date
Oct 7, 2025
Filing delay
9 daysLate
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $306.1K. It was filed 9 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Glessner ColeenCIK 0001919170Officer (EVP, Quality & Ethics, and CPL)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 7, 2025Common StockSSaleDisposed−30,608$10.00F2−$306,080144,319Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

All shares sold at an exact price of $10.00.

Referenced by the price of 1 transaction in Table I.

Remarks

This Form 4 was filed late due to an inadvertent administrative error. The Company will report all late Form 4s in its next proxy statement.

Read the full filing on SEC EDGAR (opens in a new tab)